Contenting Logo

News

Entertainment

Science & Technology

Sport

Business & Money

Life

Culture & Art

Hobbies

Sites
Lists
#tags
  1. home
    2. ›
  2. Beckers Hospital Review | Healthcare Business, Clinical and Legal News

Beckers Hospital Review | Healthcare Business, Clinical and Legal News

6 | Follower

Health

See All

Beckers Hospital Review | Healthcare Business, Clinical and Legal News

02.04.2025

Southwestern Health Resources, BCBS Texas split - Becker's Hospital Review | Healthcare News & Analysis

Farmers Branch, Texas-based Southwestern Health Resources is out of network with Blue Cross and Blue Shield of Texas as of April 1.  The split affects seven BCBS plans, including commercial, Medicaid and Medicare Advantage plans, according to a statement on BCBS Texas’ website.  “During the past several months, we worked closely with SWHR to try […]

Beckers Hospital Review | Healthcare Business, Clinical and Legal News

02.04.2025

HCA New Hampshire hospital names CEO - Becker's Hospital Review | Healthcare News & Analysis

Sean Patterson has been named CEO of Portsmouth (N.H.) Regional Hospital, part of Nashville, Tenn.-based HCA Healthcare. He began the role April 1, according to a hospital news release. Mr. Patterson most recently served as CEO of TriStar NorthCrest Medical Center in Springfield, Tenn., also part of HCA.

Beckers Hospital Review | Healthcare Business, Clinical and Legal News

02.04.2025

Yale New Haven Health opens retail pharmacy - Becker's Hospital Review | Healthcare News & Analysis

Yale New Haven (Conn.) Health opened its sixth retail pharmacy April 1, according to a news release shared with Becker’s.  The new pharmacy, located on the first floor of Bridgeport (Conn.) Hospital, operates Monday through Friday from 8 a.m. to 6 p.m. and Saturday and Sunday from 9 a.m. to 4 p.m. Through the pharmacy, […]

Beckers Hospital Review | Healthcare Business, Clinical and Legal News

02.04.2025

GLP-1 spending hits $5.8B for adults without diabetes - Becker's Hospital Review | Healthcare News & Analysis

A new study found that spending on GLP-1 medications such as Ozempic, Wegovy and Zepbound surged to $5.8 billion in 2022 among U.S. adults without diabetes.  The research, published April 1 in the Annals of Internal Medicine, showed the number of non-diabetic adults using these drugs — which are also prescribed for weight loss — […]

Contenting Logo
About UsPrivacy PolicyTerms Of UseContact